{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:38:18Z","timestamp":1787841498152,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["RS-2023-00252283"],"award-info":[{"award-number":["RS-2023-00252283"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["RS-2025-16070572"],"award-info":[{"award-number":["RS-2025-16070572"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12282-026-01879-8","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:08:25Z","timestamp":1782284905000},"page":"1047-1058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic impact of radiotherapy dose to the axilla in cN\u2009+\u2009\/ypN0 breast cancer after primary systemic therapy and sentinel lymph node biopsy: toward true de-escalation of axillary management"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-3931","authenticated-orcid":false,"given":"Tae Hoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4736-8270","authenticated-orcid":false,"given":"Won Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8442-6479","authenticated-orcid":false,"given":"Hyebin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8830-2542","authenticated-orcid":false,"given":"Tae Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3860-629X","authenticated-orcid":false,"given":"Hyunju","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4905-3317","authenticated-orcid":false,"given":"Sang Hee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4686-2071","authenticated-orcid":false,"given":"Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-8200","authenticated-orcid":false,"given":"Heerim","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1808-7573","authenticated-orcid":false,"given":"Haeyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"1879_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102297","volume":"101","author":"E Senkus","year":"2021","unstructured":"Senkus E, Cardoso MJ, Kaidar-Person O, Lacko A, Meattini I, Poortmans P. De-escalation of axillary irradiation for early breast cancer - has the time come? Cancer Treat Rev. 2021;101:102297.","journal-title":"Cancer Treat Rev"},{"key":"1879_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00744-9","volume":"11","author":"AD McCrorie","year":"2025","unstructured":"McCrorie AD, Stobart H, Dodwell D, McIntosh SA, Potter S. Mapping the current landscape of locoregional therapy de-escalation trials in early breast cancer: a systematic review. NPJ Breast Cancer. 2025;11:32.","journal-title":"NPJ Breast Cancer"},{"key":"1879_CR3","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1097\/JS9.0000000000002275","volume":"111","author":"M Zahwe","year":"2025","unstructured":"Zahwe M, Ghzaiel A, Najia A, et al. Performance of sentinel lymph node biopsy after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: systematic review and meta-analysis. Int J Surg. 2025;111:3040\u201350.","journal-title":"Int J Surg"},{"key":"1879_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.breast.2021.07.015","volume":"59","author":"S Cao","year":"2021","unstructured":"Cao S, Liu X, Cui J, et al. Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: an up-to-date meta-analysis of 3,578 patients. Breast. 2021;59:256\u201369.","journal-title":"Breast"},{"key":"1879_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s12282-025-01692-9","volume":"32","author":"V Man","year":"2025","unstructured":"Man V, Duan J, Luk WP, Fung LH, Kwong A. Different strategies in de-escalation of axillary surgery in node-positive breast cancer following neoadjuvant treatment: a systematic review and meta-analysis of long-term outcomes. Breast Cancer. 2025;32:638\u201353.","journal-title":"Breast Cancer"},{"key":"1879_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","volume":"47","author":"S Kahler-Ribeiro-Fontana","year":"2021","unstructured":"Kahler-Ribeiro-Fontana S, Pagan E, Magnoni F, et al. Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up. Eur J Surg Oncol. 2021;47:804\u201312.","journal-title":"Eur J Surg Oncol"},{"key":"1879_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4048\/jbc.2018.21.e54","volume":"21","author":"HJ Choi","year":"2018","unstructured":"Choi HJ, Kim I, Alsharif E, et al. Use of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer in diagnosis. J Breast Cancer. 2018;21:433\u201341.","journal-title":"J Breast Cancer"},{"key":"1879_CR8","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa2414859","volume":"392","author":"EP Mamounas","year":"2025","unstructured":"Mamounas EP, Bandos H, White JR, et al. Omitting regional nodal irradiation after response to neoadjuvant chemotherapy. N Engl J Med. 2025;392:2113\u201324.","journal-title":"N Engl J Med"},{"key":"1879_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","volume":"114","author":"BV Offersen","year":"2015","unstructured":"Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114:3\u201310.","journal-title":"Radiother Oncol"},{"key":"1879_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07757-6","volume":"21","author":"I Whitehead","year":"2021","unstructured":"Whitehead I, Irwin GW, Bannon F, et al. The NeST (neoadjuvant systemic therapy in breast cancer) study: national practice questionnaire of United Kingdom multi-disciplinary decision making. BMC Cancer. 2021;21:90.","journal-title":"BMC Cancer"},{"key":"1879_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.21388","volume":"6","author":"J Li","year":"2023","unstructured":"Li J, Zhou J, Wang H, et al. Trends in disparities and transitions of treatment in patients with early breast cancer in China and the US, 2011 to 2021. JAMA Netw Open. 2023;6:e2321388.","journal-title":"JAMA Netw Open"},{"key":"1879_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4048\/jbc.2023.26.e27","volume":"26","author":"JE Choi","year":"2023","unstructured":"Choi JE, Kim Z, Park CS, et al. Breast cancer statistics in Korea, 2019. J Breast Cancer. 2023;26:207\u201320.","journal-title":"J Breast Cancer"},{"key":"1879_CR13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00432-022-03938-x","volume":"149","author":"O Ortmann","year":"2023","unstructured":"Ortmann O, Blohmer JU, Sibert NT, et al. Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers. J Cancer Res Clin Oncol. 2023;149:1195\u2013209.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1879_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13058-024-01822-9","volume":"26","author":"J Bhimani","year":"2024","unstructured":"Bhimani J, O\u2019Connell K, Ergas IJ, et al. Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019. Breast Cancer Res. 2024;26:101.","journal-title":"Breast Cancer Res"},{"key":"1879_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102085","volume":"61","author":"O Kaidar-Person","year":"2023","unstructured":"Kaidar-Person O, Pfob A, Gentilini OD, et al. The Lucerne toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus. EClinicalMedicine. 2023;61:102085.","journal-title":"EClinicalMedicine"},{"key":"1879_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.21037\/tbcr-24-59","volume":"6","author":"A Tondare","year":"2025","unstructured":"Tondare A, Thorat MA. De-escalation of axillary interventions in the management of breast cancer patients following neoadjuvant systemic treatment. Transl Breast Cancer Res. 2025;6:14.","journal-title":"Transl Breast Cancer Res"},{"key":"1879_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jamaoncol.2024.0578","volume":"10","author":"G Montagna","year":"2024","unstructured":"Montagna G, Mrdutt MM, Sun SX, et al. Omission of axillary dissection following nodal downstaging with neoadjuvant chemotherapy. JAMA Oncol. 2024;10:793\u20138.","journal-title":"JAMA Oncol"},{"key":"1879_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.2752","author":"AKE van Hemert","year":"2025","unstructured":"van Hemert AKE, van Loevezijn AA, Baas MPD, et al. Iodine seed-marking protocol for response-guided axillary treatment after systemic therapy for node-positive breast cancer. JAMA Oncol. 2025. https:\/\/doi.org\/10.1001\/jamaoncol.2025.2752.","journal-title":"JAMA Oncol"},{"key":"1879_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113261","author":"H Kim","year":"2020","unstructured":"Kim H, Kim H, Park W, et al. Comparison of dose distribution in regional lymph nodes in whole-breast radiotherapy vs. whole-breast plus regional lymph node irradiation: an in silico planning study in participating institutions of the phase III randomized trial (KROG 1701). Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12113261.","journal-title":"Cancers (Basel)"},{"key":"1879_CR20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s00066-021-01808-y","volume":"197","author":"M Schmitt","year":"2021","unstructured":"Schmitt M, Pin Y, Pflumio C, Mathelin C, Pivot X, Noel G. Incidental axillary dose delivery to axillary lymph node levels I-III by different techniques of whole-breast irradiation: a systematic literature review. Strahlenther Onkol. 2021;197:820\u20138.","journal-title":"Strahlenther Onkol"},{"key":"1879_CR21","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S1470-2045(22)00482-X","volume":"23","author":"SR de Wild","year":"2022","unstructured":"de Wild SR, de Munck L, Simons JM, et al. De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010\u201303): 5-year follow-up results of a Dutch, prospective, registry study. Lancet Oncol. 2022;23:1201\u201310.","journal-title":"Lancet Oncol"},{"key":"1879_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3857\/roj.2024.00248","volume":"42","author":"ML Gasparri","year":"2024","unstructured":"Gasparri ML, Kaidar-Person O, Gentilini OD, de Boniface J, Kuehn T, Poortmans P. Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey. Radiat Oncol J. 2024;42:308\u201318.","journal-title":"Radiat Oncol J"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01879-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:58:26Z","timestamp":1787839106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01879-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1879"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01879-8","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of the participating hospitals (approval number 2024\u201309-057). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The requirement for informed consent was waived due to the retrospective design of the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}